Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation

RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA and NATSUO OYA
Anticancer Research January 2022, 42 (1) 205-209; DOI: https://doi.org/10.21873/anticanres.15474
RYO TOYA
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: ryo108{at}kumamoto-u.ac.jp
TAKAHIRO WATAKABE
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DAIZO MURAKAMI
2Department of Otolaryngology–Head and Neck Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TOMOHIKO MATSUYAMA
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TETSUO SAITO
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YOSHIYUKI FUKUGAWA
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
KOHEI NISHIMOTO
2Department of Otolaryngology–Head and Neck Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YORIHISA ORITA
2Department of Otolaryngology–Head and Neck Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
NATSUO OYA
1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 42 no. 1 205-209
DOI 
https://doi.org/10.21873/anticanres.15474
PMID 
34969726

Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received November 8, 2021
  • Revision received November 25, 2021
  • Accepted November 26, 2021
  • Published online December 29, 2021.

Copyright & Usage 
Copyright © 2022 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Author Information

  1. RYO TOYA1⇑,
  2. TAKAHIRO WATAKABE1,
  3. DAIZO MURAKAMI2,
  4. TOMOHIKO MATSUYAMA1,
  5. TETSUO SAITO1,
  6. YOSHIYUKI FUKUGAWA1,
  7. KOHEI NISHIMOTO2,
  8. YORIHISA ORITA2 and
  9. NATSUO OYA1
  1. 1Department of Radiation Oncology, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  2. 2Department of Otolaryngology–Head and Neck Surgery, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan
  1. Correspondence to: Ryo Toya, MD, Department of Radiation Oncology, Kumamoto University Hospital, 1-1-1 Honjo, Chuo-ku, Kumamoto 860-8556, Japan. Tel: +81 963735520, Fax: +81 963735520, e-mail: ryo108{at}kumamoto-u.ac.jp
View Full Text

Statistics from Altmetric.com

Cited By...

  • 3 Citations
  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 42, Issue 1
January 2022
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
6 + 1 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA, NATSUO OYA
Anticancer Research Jan 2022, 42 (1) 205-209; DOI: 10.21873/anticanres.15474

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation
RYO TOYA, TAKAHIRO WATAKABE, DAIZO MURAKAMI, TOMOHIKO MATSUYAMA, TETSUO SAITO, YOSHIYUKI FUKUGAWA, KOHEI NISHIMOTO, YORIHISA ORITA, NATSUO OYA
Anticancer Research Jan 2022, 42 (1) 205-209; DOI: 10.21873/anticanres.15474
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Risk of Non-colorectal Malignancies in Sporadic Versus Lynch Syndrome–associated dMMR Colorectal Cancer
  • Evaluation of Radiotherapy Dose in Secondary Breast Angiosarcoma: Implications for Pathogenesis
  • Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Outcomes for Colorectal and Mesothelioma Peritoneal Metastases: A 12-year Study
Show more Clinical Studies

Keywords

  • head and neck cancer
  • glottic carcinoma
  • radiotherapy
  • Chemoradiotherapy
  • laryngeal preservation
  • elective nodal irradiation
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire